Cargando…
Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
PURPOSE OF REVIEW: Lipoprotein(a) is an independent risk factor for cardiovascular disease. We review the ongoing shifts in consensus guidelines for the testing and management of Lp(a) and provide insight into whether current evidence suggests that awareness and testing of Lp(a) is clinically action...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651710/ https://www.ncbi.nlm.nih.gov/pubmed/37632608 http://dx.doi.org/10.1007/s11886-023-01937-z |